{"id":"sozoiodolic-acid","rwe":[],"tags":[{"label":"sozoiodolic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ronozol","offLabel":[],"synonyms":["sozoiodolic acid","ronozol","sozojodol","sozoiodol sodium","sozoiodol zinc"],"timeline":[],"approvals":[],"brandName":"Ronozol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"sozoiodolic acid","explanation":"Imagine your body's cells are like locks, and Ronozol is a key that fits into those locks. When Ronozol binds to its target, it can either block or enhance the activity of the cell, depending on the specific effect desired. This can help to restore balance to the body's systems and alleviate symptoms of disease.","oneSentence":"Ronozol works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Ronozol's mechanism of action is likely to involve the modulation of protein-protein interactions or the binding to specific receptors, which can trigger downstream signaling pathways to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3830","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=sozoiodolic acid","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:40:56.015956","biosimilars":[],"competitors":[],"genericName":"sozoiodolic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"PTH3749NIR","CHEBI":"CHEBI:135689","UMLSCUI":"C0603937","PUBCHEM_CID":"68193","MESH_SUPPLEMENTAL_RECORD_UI":"C009297"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Ronozol, also known as sozoiodolic acid, is a small molecule drug of unknown target and class. Its commercial status and approved indications are currently unknown. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand Ronozol's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}